Table 2 Univariate analysis of demographic and clinical factors associated with receipt of adjuvant chemotherapy
From: Factors associated with receipt of adjuvant chemotherapy among married women with breast cancer
Variable | Number of cases (N = 1,431) | Percent that received adjuvant chemotherapy (N = 936) | χ 2 P |
|---|---|---|---|
Age at diagnosis (years) | |||
<50 | 780 | 79.62% | 0.030 |
50 to 69 | 572 | 65.38% | |
≥70 | 79 | 51.90% | |
Neoadjuvant chemotherapy received | |||
No | 1,075 | 60.28% | <0.001 |
Yes | 356 | 80.90% | |
Comorbidities | |||
None | 1,024 | 65.43% | 0.979 |
One or more | 407 | 65.36% | |
Menopausal status | |||
Premenopause | 703 | 66.29% | 0.492 |
Menopause | 728 | 64.56% | |
Residential status | |||
Rural | 453 | 61.15% | 0.021 |
Urban | 978 | 67.38% | |
Tumor size | |||
≤2 | 1,088 | 67.2% | 0.369 |
>2 | 214 | 64.0% | |
Lymph node metastasis | |||
Negative | 823 | 61.6% | <0.001 |
Positive | 606 | 70.6% | |
Distant metastasis | |||
Negative | 1,421 | 65.4% | 0.759 |
Positive | 10 | 70.0% | |
Tumor stage | |||
I | 178 | 64.0% | 0.614 |
II | 927 | 67.6% | |
III | 198 | 63.6% | |
IV | 10 | 70.0% | |
Hormone receptor status | |||
ER- and PR- | 203 | 61.58% | 0.082 |
ER + and/or PR+ | 648 | 71.91% | |